Hirohito Tada

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe et al. · The Lancet Oncology · 2009 · 4.1K citations

Open Label, Medicine, Cancer Growth +10

A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung

Harubumi Kato, Yukito Ichinose, Morio Ohta et al. · New England Journal of Medicine · 2004 · 828 citations · Full text

A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)

Kenji Suzuki, Teruaki Koike, T. Asakawa et al. · Journal of Thoracic Oncology · 2011 · 644 citations · Full text

Computed Tomography, Thin-section Computed Tomography, Prospective Radiological Study +11

Analysis of <i>Epidermal Growth Factor Receptor</i> Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib

Takayuki Kosaka, Yasushi Yatabe, Hideki Endoh et al. · Clinical Cancer Research · 2006 · 587 citations · Full text

A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L)

Kenichi Nakamura, Hisashi Saji, R. Nakajima et al. · Japanese Journal of Clinical Oncology · 2009 · 525 citations · Full text